Resistance Mechanisms Determining the In Vitro Sensitivity to Paclitaxel of Tumour Cells Cultured from Patients with Ovarian Cancer

Author： Baguley B.C.   Marshall E.S.   Whittaker J.R.   Dotchin M.C.   Nixon J.   McCrystal M.R.   Finlay G.J.   Matthews J.H.L.   Holdaway K.M.   van Zijl P.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.31, Iss.2, 1995-01, pp. : 230-237

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sensitivity to paclitaxel is not related to p53-dependent apoptosis in ovarian cancer cells

By Takahashi M.   Kigawa J.   Minagawa Y.   Itamochi H.   Shimada M.   Kamazawa S.   Sato S.   Akeshima R.   Terakawa N.  

European Journal of Cancer, Vol. 36, Iss. 14, 2000-09 ,pp. : 1863-1868

Elsevier

Access to resources Recommend Favorite

hMSH2 expression is associated with paclitaxel resistance in ovarian carcinoma, and inhibition of hMSH2 expression in vitro restores paclitaxel sensitivity

By      

Oncology Reports, Vol. 32, Iss. 5, 2014-01 ,pp. : 2199-2206

Spandidos Publications

Access to resources Recommend Favorite

A2780 human ovarian cancer cells with acquired paclitaxel resistance display cancer stem cell properties

By                            

Oncology Letters, Vol. 6, Iss. 5, 2013-01 ,pp. : 1295-1298

Spandidos Publications

Access to resources Recommend Favorite

miR21 modulates paclitaxel sensitivity and hypoxiainducible factor1α expression in human ovarian cancer cells

By      

Oncology Letters, Vol. 6, Iss. 3, 2013-01 ,pp. : 795-800

Spandidos Publications

Access to resources Recommend Favorite

Acquisition of paclitaxel resistance via PI3Kdependent epithelialmesenchymal transition in A2780 human ovarian cancer cells

By                            

Oncology Reports, Vol. 30, Iss. 3, 2013-01 ,pp. : 1113-1118

Spandidos Publications

Access to resources Recommend Favorite